Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,993842,119217,53141,100491,89650,55698,104621,154592,42199,64444,41679,168110
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,325393,37499,15051,21279,25028,20410,44360,26091,16834,31841,20925,66075
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,28126,5468,1254,1595,2341,1391,4074,1567,597,1461,1882,6496
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,563171,69713,25237,66570,47510,31174,80863,57542,25260,33493,28160,97649
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,287858,31841,16079,22318,26819,20234,38239,32360,15485,23168,19794,41521
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,252056,30227,16090,19152,24132,18588,32677,25046,13926,20666,18440,33112
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,524760,47307,22138,68933,53404,26889,68443,54214,21918,24026,27060,110428
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,21484,1317,1426,2794,879,430,3375,1381,1466,595,2976,4845
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1509,383,21,272,49,33,162,185,82,21,15,286
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,296771,30791,14178,35564,31240,16588,54961,29134,8266,19637,25231,31181
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15482,788,418,1860,1224,258,3121,2768,361,283,1902,2499
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,28412,1308,986,2446,1121,2223,975,2701,7301,7044,423,1884
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1234,0,167,10,9,0,70,0,451,481,8,38
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,15263,948,655,446,3180,2306,1583,591,1387,1215,972,1980
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,16497,948,822,456,3189,2306,1653,591,1838,1696,980,2018
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,8457,685,532,271,1595,903,481,474,772,935,540,1269
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,62,11,0,30,0,1,1,0,8,2,9,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,211930,34641,8784,43963,7687,5703,32906,35255,5456,3761,10353,23421
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,99065,20784,4745,31098,3020,3967,3049,5740,3401,2082,7891,13288
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,12526,2157,657,1000,2229,364,2424,603,416,201,1193,1282
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3580,907,579,620,2,53,85,77,279,111,744,123
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,43087,9067,3406,198,893,211,7467,3238,4444,5326,1876,6961
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,12,0,0,0,NA,NA,12,0,0,0,0,0
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,29,0,NA,29,NA,0,0,0,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,50014,8565,1733,11725,481,563,7458,9469,1717,505,1751,6047
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,50043,8565,1733,11754,481,563,7458,9469,1717,505,1751,6047
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,25482,5365,2228,109,336,141,4897,2039,2105,2768,1142,4352
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,141169,23230,6788,22994,6055,4182,21799,20335,6208,5765,7003,16810
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,128197,21076,6111,21031,5628,4013,19868,18237,5581,5136,6131,15385
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,269366,44306,12899,44025,11683,8195,41667,38572,11789,10901,13134,32195
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,5111,942,175,1131,144,50,836,918,143,87,112,573
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,38114,5814,3978,2894,2138,437,6100,4040,2595,2495,1745,5878
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,258597,42725,12576,42534,10720,7099,40652,38405,11250,9931,12893,29812
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,55758,9936,2417,6360,2123,1279,9103,11791,1820,1185,2051,7693
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,198179,29923,8165,35725,10423,6596,29065,30974,8794,7230,10433,20851
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,0,0,0,0,0,0,0,6,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,894,0,6,0,10,456,44,242,NA,135,NA,1
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,74434,18554,4458,9545,5977,310,7140,13106,4415,645,2261,8023
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,75334,18554,4464,9545,5987,766,7184,13348,4421,780,2261,8024
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,9303,1369,275,0,388,134,1155,1096,1825,2117,401,543
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,56846,12054,4721,6690,1039,456,7414,9403,3081,2795,2083,7110
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5565,482,28,1027,172,248,345,1377,324,156,179,1227
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,53734,18286,3621,5067,1561,559,6310,5001,3542,2793,1372,5622
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,16870,2072,1551,2733,504,77,2438,3124,330,175,374,3492
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,234942,35351,10371,43021,10617,7299,35533,33013,10340,9644,12741,27012
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,168874,22137,7142,15870,8676,6725,22950,21741,4134,8710,16706,34083
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,6263,657,1486,784,303,1,1289,263,69,307,428,676
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,6754,1210,85,964,249,42,1196,605,645,387,303,1068
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,872,104,13,202,7,0,80,153,235,0,14,64
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7626,1314,98,1166,256,42,1276,758,880,387,317,1132
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,13630,2068,2678,79,432,24,2006,1185,898,1617,720,1923
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,36523,5671,1969,7213,2273,1384,2418,1269,2601,2943,3171,5611
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,185417,22197,11564,25107,12077,13240,17854,10645,6467,9931,9847,46488
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,221940,27868,13533,32320,14350,14624,20272,11914,9068,12874,13018,52099
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,919,0,22,0,2,212,6,0,68,32,16,561
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,0,0,0,0,0,NA,0,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1293,829,20,118,8,10,45,25,15,3,155,65
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1293,829,20,118,8,10,45,25,15,3,155,65
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,30,27,1,0,0,NA,1,0,1,0,0,0
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,5,0,NA,0,1,0,0,0,NA,4,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,6896,2140,33,1111,72,14,947,441,679,91,288,1080
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,6901,2140,33,1111,73,14,947,441,679,95,288,1080
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,3087,57,42,301,15,NA,1535,780,24,287,7,39
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,4,4,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2,0,NA,2,NA,0,0,0,NA,0,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1892,222,136,961,53,3,152,131,40,6,94,94
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1898,226,136,963,53,3,152,131,40,6,94,94
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,347,25,11,0,3,NA,199,0,17,64,0,28
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,15,0,NA,15,NA,0,0,0,NA,0,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4791,599,2,820,39,46,1274,967,168,53,113,710
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4806,599,2,835,39,46,1274,967,168,53,113,710
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,351,93,10,0,17,NA,33,4,13,71,7,103
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,13,13,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,22551,3382,1493,1114,1477,1898,2351,1381,1984,2124,2168,3179
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7806,958,694,445,528,1029,699,734,NA,844,153,1722
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,50006,7942,2347,8077,4028,1121,9117,6311,1892,1147,1564,6460
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,80376,12295,4534,9636,6033,4048,12167,8426,3876,4115,3885,11361
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,43669,6953,2369,7015,3369,1397,7505,5469,1081,1072,1088,6351
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,3876,569,224,177,235,52,593,460,257,600,161,548
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,13602,1705,929,1209,969,847,1784,1029,963,1103,1094,1970
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,199092,20464,13764,14491,18898,13629,22959,19707,13151,24136,14849,23044
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,6879685,825826,229251,505713,706434,358426,1150211,346626,650470,802091,548889,755748
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,328,63,0,0,7,80,0,0,55,104,8,11
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,17691,1286,1529,1097,1849,1999,2285,1122,1853,1214,1377,2080
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,17,1,0,0,0,0,0,12,0,0,2,2
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,46,15,0,6,2,0,7,10,1,0,0,5
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,635,70,59,76,32,9,147,81,58,24,31,48
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,304598,41441,15915,48224,18204,13414,43700,41055,13223,16356,15365,37701
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,17015,2237,991,252,685,797,2374,1536,1767,2954,395,3027
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,14115,2065,834,223,591,747,1701,965,1395,2609,379,2606
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,13171,2055,737,211,584,649,1674,923,989,2489,330,2530
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,295876,29587,19414,17195,28752,28572,38269,26425,17610,27833,22926,39293
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,289911,28041,19950,15207,28971,28083,37949,24167,17719,28429,22717,38678
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,284421,27302,19246,14861,28636,26661,37219,23434,17857,28014,22551,38640
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,241194,36618,12257,42992,9361,7039,35810,37086,10198,8386,12055,29392
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,306118,31766,20496,17184,28969,28967,39350,27100,16597,30390,23188,42111
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,298659,30072,20674,15189,29115,28527,38497,24678,17098,30560,23107,41142
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,292750,29286,19982,14834,28642,26915,37772,23786,17262,30336,22889,41046
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,226530,32433,11909,42823,8648,6140,34588,35596,9254,7721,11764,25654
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,17432,2726,1466,119,238,1105,2486,1717,1017,2552,433,3573
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,12163,1906,1157,149,197,493,1753,1060,1026,2159,323,1940
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,10811,2083,844,180,303,453,1376,909,956,1711,334,1662
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,312133,30557,21644,15863,31011,28600,40366,24915,19720,32416,24313,42728
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,87726,8244,7089,3839,6027,8662,14255,5931,4456,10063,4632,14528
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,11,0,0,0,10,0,0,0,1,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,160648,15480,11196,8294,16243,14682,21157,12497,9504,15942,12971,22682
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,139477,13534,9777,7009,14053,12993,18390,11004,8413,13832,10943,19529
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,300125,29014,20973,15303,30296,27675,39547,23501,17917,29774,23914,42211
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,311736,30371,22140,15769,30582,28460,40180,24198,19858,30986,24952,44240
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,310757,30305,21971,15762,30401,28295,39807,24453,20217,30895,24945,43706
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,228613,23196,15366,12128,23422,19095,26855,19592,16285,24362,19551,28761
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,44792,5055,1598,2120,4543,5678,7024,4252,1703,1740,3022,8057
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,38010,4277,1388,1459,3656,5262,6183,3495,1516,1527,2506,6741
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,82802,9332,2986,3579,8199,10940,13207,7747,3219,3267,5528,14798
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,159075,17395,12025,9035,13366,12017,19641,11732,10775,15790,14073,23226
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,43748,5343,3705,3872,2821,3164,4469,3056,3548,4993,3765,5012
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,27006,4284,2078,2237,2539,1593,3154,2603,1776,2443,2294,2005
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11,0,7,0,0,0,4,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1,0,0,0,0,0,0,0,0,1,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26,6,3,0,0,8,3,2,1,3,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,124988,16784,9823,7492,12215,8632,17081,7866,6886,12941,8052,17216
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,120939,16389,9558,7003,11837,8413,16505,7607,6737,12472,7740,16678
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,64615,3678,6134,2837,6497,6792,8048,3518,3601,7716,6123,9671
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4,0,0,0,0,0,0,0,0,4,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,247616,21252,19941,11219,21476,21167,31568,20226,17673,25599,23125,34370
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,171012,11420,17317,4606,23989,12153,20144,14139,10623,18973,11310,26338
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,73473,4430,8165,2174,8971,7001,9471,5402,4474,9989,4326,9070
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,7,0,2,4,0,0,1,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,3,0,0,3,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,24,0,0,9,0,0,0,3,0,0,0,12
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,641,98,48,75,70,12,96,122,69,27,5,19
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,102416,9660,9446,10561,26340,1606,8654,5212,3340,6255,4072,17270
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1035,163,79,326,191,0,115,65,34,25,19,18
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19698,2071,2109,5560,1128,46,2426,1155,2054,370,488,2291
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,60482,30493,1141,8154,774,358,5175,2483,574,3209,140,7981
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,57405,30142,589,8053,413,357,4378,1817,568,3105,96,7887
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,24531,1463,342,0,1892,640,3503,3736,2099,757,960,9139
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,2572,0,0,0,0,0,697,0,0,0,0,1875
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,1363,929,0,101,0,0,0,28,0,0,0,305
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,906,528,0,65,0,0,0,8,0,0,0,305
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,471,69,25,48,31,45,104,65,11,13,12,48
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,4973,72,64,0,36,268,3223,112,438,594,67,99
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,405,48,46,12,35,46,72,60,NA,14,24,48
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,62,6,3,0,4,10,21,4,0,2,7,5
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2026,168,395,300,52,53,239,134,97,122,317,149
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,47849,3518,6143,13512,1159,1405,5660,2450,1248,3149,3213,6392
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,668,109,52,65,28,7,101,79,63,62,44,58
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1931,382,175,389,25,0,507,66,42,148,59,138
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,454,0,205,0,122,NA,0,2,NA,NA,125,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,22478,885,1154,19380,31,NA,356,0,NA,NA,16,656
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,45078,8032,3740,31800,67,NA,646,0,NA,NA,23,770
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,301738,62156,20518,73369,9405,2491,42744,25904,16564,16826,10674,21087
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,637187,197605,31536,86789,6720,4840,95364,62851,29454,43057,18246,60725
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,221409,29248,13422,67671,7026,2305,34775,19953,11591,10034,8602,16782
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,811793,161875,48440,120045,18249,13349,131038,105384,35401,51616,31650,94746
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,523147,91404,33940,141040,16431,4796,77519,45857,28155,26860,19276,37869
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1448980,359480,79976,206834,24969,18189,226402,168235,64855,94673,49896,155471
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,27354,8773,2027,5882,470,12,4148,1329,1017,809,237,2650
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,16095,4525,1198,3545,195,23,2616,970,638,463,132,1790
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,43449,13298,3225,9427,665,35,6764,2299,1655,1272,369,4440
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,5100075,867599,341956,1360624,131732,37767,671491,353361,315080,391983,147198,481284
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,65243142,9033211,3733340,9795295,3889816,2885916,8657254,6896279,3293680,4107679,4325777,8624895
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,355227,83609,22869,65253,3936,2406,45605,22004,28217,31997,6445,42886
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,13372,1469,570,868,211,65,1516,443,6919,448,319,544
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,18909,549,1853,12365,243,NA,3025,0,NA,357,417,100
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,688835,47812,41795,91825,37902,10277,127006,29187,10997,24275,8654,259105
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,116,4,29,36,0,NA,41,0,NA,NA,3,3
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,2010189,293523,249293,220104,173618,4833,180451,271398,46718,210640,107141,252470
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,563446,144759,13912,145549,30207,1446,65486,19490,9511,29048,30800,73238
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,75802,16054,5303,4364,8689,4343,15366,3397,480,3089,8099,6618
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,4390882,2614224,361724,765909,126639,NA,220827,131177,NA,9529,127269,33584
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,11307542,2196315,387433,5847752,180253,97032,688006,500054,379498,192999,232274,605926
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,137550,24109,7384,16111,5770,3375,18602,17861,3909,2244,4878,33307
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,502470,61591,31085,57370,10238,7299,42700,21848,221957,9623,9909,28850
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3143,452,155,929,89,109,596,298,155,40,73,247
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,216250,30070,16008,34089,9479,8541,31577,19235,26174,8516,8492,24069
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1219,123,77,405,26,32,235,84,50,13,32,142
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,301284,41898,19126,34445,26256,22337,46271,33248,14510,11381,23952,27860
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,920,45,22,105,16,188,124,318,30,7,13,52
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1020004,133559,66219,125904,45973,38177,120548,74331,262641,29520,42353,80779
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5282,620,254,1439,131,329,955,700,235,60,118,441
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,312404,29678,20378,32407,22142,8121,51678,33259,15686,15437,23446,60172
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,65080,6191,15618,18824,2533,824,3061,2703,6189,2041,1470,5626
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,76624,8706,3611,24108,4762,2875,7081,1990,3729,1952,2149,15661
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,289258,33707,15973,32681,21767,18055,53247,24097,14081,13539,29117,32994
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,430962,48604,35202,75613,29062,21754,63389,28790,23999,17532,32736,54281
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,652979,35125,18464,42594,11709,6030,63201,58543,304125,28649,30748,53791
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3606,177,292,354,84,46,525,493,637,386,222,390
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,777,11,20,31,0,5,412,5,22,251,16,4
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,436839,33710,23530,33150,41770,28419,41990,14610,52290,39880,45380,82110
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,506240,54500,37000,31250,39220,29500,67630,38700,35440,50500,47500,75000
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,22180,2560,1220,0,0,0,18400,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,499086,53020,38000,32420,35520,30696,68270,38730,37120,52620,46390,66300
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,421813,32630,21310,31980,45470,27223,22950,14580,50610,37760,46490,90810
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,558530,45580,17120,45430,47460,43420,70400,31320,62440,71720,56290,67350
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,852940,89700,59660,52140,68640,55420,129080,78270,52510,82580,62080,122860
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12870,490,0,0,0,0,12380,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,785741,82670,56240,49980,63100,40728,120903,73740,49880,79380,61690,107430
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,612859,52120,20540,47590,53000,58112,66197,35850,65070,74920,56680,82780
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,812180,99960,34990,66300,78230,50880,81520,38180,104600,93640,86700,77180
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,1395660,172540,94040,150780,98000,72000,147080,126000,98200,117000,90000,230020
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11020,1760,0,0,0,0,9260,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1329077,184340,88610,146280,87890,51747,139940,118420,86800,105690,97040,222320
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,867743,86400,40420,70800,88340,71133,79400,45760,116000,104950,79660,84880
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,556498,100110,16950,54530,42080,28528,70940,24901,66200,63479,71080,17700
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,629410,79500,33560,42500,44000,33490,102500,40500,32170,66500,64000,90690
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,12870,0,0,0,0,0,12870,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,588247,73040,33550,41270,40140,26212,93590,39350,30290,60885,62860,87060
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,584791,106570,16960,55760,45940,35806,66980,26051,68080,69094,72220,21330
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,11400,0,0,NA,11400,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,18300,0,0,NA,18300,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,16200,0,0,NA,16200,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,13500,0,0,0,13500,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,419225,23470,19560,55180,37110,19235,60320,20400,75860,52360,20870,34860
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,504710,48000,25600,83000,35000,24500,83000,53850,24260,38500,21000,68000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,16790,1620,0,0,0,0,15170,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,475743,45910,25970,75690,32900,19773,81810,49530,25690,36920,20530,61020
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,431402,23940,19190,62490,39210,23962,46340,24720,74430,53940,21340,41840
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,496032,34565,20515,51795,40370,32037,53450,20430,64215,53640,54025,70990
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,550050,58000,38690,30300,47500,36750,88000,42970,33340,56000,37000,81500
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,12500,1600,0,0,0,0,10900,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,497004,49800,38485,28735,41760,27109,81650,41515,31355,53930,34825,67840
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,536578,41165,20720,53360,46110,41678,48900,21885,66200,55710,56200,84650
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,214746,17860,18770,36480,13750,7186,38320,20140,14520,12080,16580,19060
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,223620,31710,8990,47000,9070,4100,34340,37230,5180,9000,10800,26200
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,7460,280,0,0,0,0,7180,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,209065,28830,9850,43050,8180,2945,33040,33350,6090,8850,10070,24810
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,221841,20460,17910,40430,14640,8341,32440,24020,13610,12230,17310,20450
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,86323,11852,5009,4541,14979,6369,9473,9120,5839,6725,9350,3066
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,49583,6000,2633,5600,5400,1750,7200,5900,1800,2700,3400,7200
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1539,219,0,0,0,0,895,NA,0,0,0,425
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,48958,2681,2151,2854,4009,3256,7095,14565,2157,2495,1780,5915
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,85409,14952,5491,7287,16370,4863,8683,455,5482,6930,10970,3926
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,4806782,137760,119560,624140,292630,163472,2653200,86680,378000,329400,21940,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,2623110,176760,87100,156600,201730,139800,689400,200220,454000,517500,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,983640,8640,0,0,0,0,975000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,2510257,157024,83840,116820,192320,128123,870600,182460,356000,404100,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,3935995,148856,122820,663920,302040,175149,1497000,104440,476000,442800,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,258925,15441,15968,28290,43650,14239,18547,16190,26550,25970,29775,24305
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,136671,15500,7471,13500,16400,5750,14000,20950,9000,14000,7500,12600
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,7013,3231,0,0,0,0,3782,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,124894,14009,6084,11810,14510,5606,15615,16920,10600,13800,6285,9655
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,263689,13701,17355,29980,45540,14383,13150,20220,24950,26170,30990,27250
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,99157,4576,11965,5334,20100,3070,17628,9100,6145,3395,13775,4069
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,21050,1500,3225,900,2400,1500,600,4400,1620,1905,2200,800
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,7171,61,0,0,0,0,7110,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,18391,1691,2425,401,1490,1199,3370,3100,1120,1535,810,1250
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,94645,4324,12765,5833,21010,3371,7748,10400,6645,3765,15165,3619
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,12334,NA,0,1600,0,0,6464,720,1550,0,1800,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,8700,NA,0,1800,0,0,2000,1300,800,0,1300,1500
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,0,0,0,664,0,0,0,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,5850,NA,0,1400,0,0,1200,850,500,0,900,1000
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,14520,0,0,2000,0,0,6600,1170,1850,0,2200,700
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,2,NA,0,NA,0,2,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,-2,0,0,0,0,-2,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,2755650,203450,0,664500,606000,89000,415200,52100,241500,328500,155400,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,1975000,210000,0,330000,510000,210000,10000,105000,270000,300000,30000,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,30000,NA,0,0,0,0,30000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,1803950,241750,0,275650,407900,106250,120600,105000,254550,256050,36200,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,2896700,171700,0,718850,708100,192750,274600,52100,256950,372450,149200,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,63000,NA,0,NA,0,63000,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,39500,NA,0,NA,0,39500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,46500,NA,0,NA,0,46500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,56000,0,0,0,0,56000,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,19339,NA,837,572,930,1168,10802,962,1555,652,1802,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,8098,NA,800,550,800,503,2160,955,700,930,600,100
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,148,NA,0,0,0,0,148,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,9438,NA,1160,553,863,1230,1622,1028,776,938,1109,159
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,17851,0,477,569,867,441,11192,889,1479,644,1293,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,229500,NA,0,21000,27400,96880,4200,14700,11600,47700,6020,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,224200,NA,0,17200,48600,35200,41600,5000,38600,38000,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,210115,NA,0,15050,45400,27405,41600,6800,37000,33300,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,243585,0,0,23150,30600,104675,4200,12900,13200,52400,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,513712,39808,31726,99785,27950,15466,80200,21900,81700,57650,35977,21550
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,394747,36000,29945,70000,39500,4462,56000,45450,18590,32000,18000,44800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,19000,800,0,0,0,0,18200,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,338007,30486,24786,58700,31400,6550,49800,38400,13450,27850,16860,39725
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,551452,44522,36885,111085,36050,13378,68200,28950,86840,61800,37117,26625
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,3612570,334590,52860,187460,710440,86000,265400,84200,860900,445300,315450,269970
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,2598150,283800,171500,126800,279000,93600,392400,217350,194500,206000,250400,382800
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,205000,101700,0,0,0,0,103300,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2497720,263580,167100,126470,252720,96500,386300,199050,172300,255700,221900,356100
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,3508000,253110,57260,187790,736720,83100,168200,102500,883100,395600,343950,296670
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,515770,66400,40700,14450,23900,12475,50500,33400,107230,96800,34985,34930
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,271025,14500,19500,7400,16700,2995,62300,21800,11530,74000,12000,28300
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,31700,12600,0,0,0,0,19100,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,220112,13880,16220,5200,17200,3600,38300,18700,9800,56500,15541,25171
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,534983,54420,43980,16650,23400,11870,55400,36500,108960,114300,31444,38059
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,158,29,1,18,7,10,85,2,1,2,1,2
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,537,75,218,175,4,1,34,3,5,NA,5,17
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,117,12,27,47,5,NA,24,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,654,87,245,222,9,1,58,3,5,NA,6,18
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,357,51,76,158,13,NA,43,3,8,NA,3,2
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,22,3,3,7,1,NA,6,NA,NA,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,379,54,79,165,14,NA,49,3,8,NA,4,3
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,526,76,7,176,7,6,62,1,6,1,3,181
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,29,6,1,4,3,NA,14,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,555,82,8,180,10,6,76,2,6,1,3,181
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,752,63,150,229,9,8,173,5,3,8,11,93
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,71,5,14,15,4,3,29,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,823,68,164,244,13,11,202,5,3,8,11,94
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,207,12,46,107,8,1,19,1,3,NA,4,6
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,89,3,20,54,2,NA,6,2,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,296,15,66,161,10,1,25,3,4,NA,4,7
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,48,1,NA,32,1,1,9,1,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,16,NA,NA,13,NA,NA,1,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,64,1,NA,45,1,1,10,1,1,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,62,2,NA,50,NA,2,2,NA,1,NA,2,3
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,52,NA,NA,43,2,NA,3,NA,2,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,114,2,NA,93,2,2,5,NA,3,NA,2,5
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,544,28,119,246,14,9,75,17,13,1,5,17
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,214,10,39,97,9,2,23,4,3,NA,2,25
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,758,38,158,343,23,11,98,21,16,1,7,42
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,11,1,NA,6,1,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,163,33,4,92,1,NA,24,1,NA,NA,2,6
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,93,18,2,31,NA,NA,32,1,NA,NA,NA,9
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,267,52,6,129,2,NA,58,2,NA,NA,2,16
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,32,2,NA,19,NA,NA,9,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,479,30,13,205,5,NA,145,12,1,1,3,64
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,341,22,10,174,7,NA,69,7,NA,3,20,29
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,852,54,23,398,12,NA,223,19,1,4,23,95
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,81,6,5,57,2,NA,3,2,1,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,886,110,77,286,23,NA,207,24,8,18,13,120
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1315,189,174,222,37,NA,344,39,11,36,43,220
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2282,305,256,565,62,NA,554,65,20,54,56,345
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,3,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,17,2,1,5,NA,NA,6,NA,1,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,21,2,1,8,NA,NA,7,NA,1,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,95,2,1,67,1,NA,18,1,1,1,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,386,44,10,86,13,NA,172,2,NA,1,3,55
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,233,52,6,24,8,NA,107,1,5,4,1,25
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,714,98,17,177,22,NA,297,4,6,6,4,83
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,1,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,76,3,1,19,NA,NA,31,1,NA,NA,1,20
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,7,NA,NA,3,NA,NA,4,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,84,3,1,23,NA,NA,35,1,NA,NA,1,20
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,35,4,3,11,2,NA,10,1,1,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1219,131,81,401,78,NA,235,43,16,14,57,163
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2278,306,168,677,66,NA,416,58,78,39,109,361
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3532,441,252,1089,146,NA,661,102,95,53,167,526
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,36,2,NA,21,1,NA,10,1,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,388,46,24,72,9,NA,152,35,NA,NA,4,46
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,433,64,64,43,3,NA,191,12,1,NA,21,34
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,857,112,88,136,13,NA,353,48,1,NA,25,81
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,4,NA,NA,1,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,4,NA,NA,1,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,51,12,NA,28,NA,NA,7,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,51,12,NA,28,NA,NA,7,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,36,11,NA,12,NA,NA,9,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,36,11,NA,12,NA,NA,9,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,34,4,1,25,NA,1,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,34,4,1,25,NA,1,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,297,35,6,82,4,1,33,90,4,NA,2,40
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,297,35,6,82,4,1,33,90,4,NA,2,40
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,41,NA,5,30,2,NA,3,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,982,36,66,527,100,NA,128,5,2,NA,17,101
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,208,13,24,76,13,NA,40,1,1,NA,6,34
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1231,49,95,633,115,NA,171,6,3,NA,23,136
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,3,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,60,2,1,2,18,NA,22,1,NA,NA,12,2
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,9,1,2,2,1,NA,2,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,72,6,3,4,19,NA,24,1,NA,NA,13,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,2,1,NA,NA,NA,NA,NA,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,14,NA,1,2,3,NA,5,NA,NA,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,4,NA,NA,NA,1,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,20,1,1,2,4,NA,7,NA,NA,NA,2,3
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,217,19,100,90,NA,NA,6,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2138,235,6,1563,13,NA,183,8,7,NA,5,118
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1549,310,6,984,5,NA,112,14,41,NA,7,70
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3904,564,112,2637,18,NA,301,22,48,NA,12,190
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,76,11,10,43,NA,NA,10,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1730,237,46,729,16,NA,411,45,NA,3,15,228
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1709,343,64,534,14,NA,440,67,15,4,30,198
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3515,591,120,1306,30,NA,861,112,15,7,45,428
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,30,1,15,2,1,NA,5,4,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1322,48,462,151,77,NA,304,131,3,43,22,81
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1035,19,274,69,24,NA,287,182,23,65,76,16
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2387,68,751,222,102,NA,596,317,26,108,98,99
